ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 19 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,298 | -12.4% | 17,851 | -16.4% | 0.75% | -22.2% |
Q2 2023 | $10,609 | +21.1% | 21,351 | -2.3% | 0.96% | +30.3% |
Q1 2023 | $8,764 | +31.0% | 21,851 | +79.6% | 0.74% | +50.2% |
Q4 2022 | $6,690 | -99.9% | 12,164 | -17.6% | 0.49% | -12.0% |
Q3 2022 | $8,274,000 | +1.8% | 14,764 | 0.0% | 0.56% | -4.1% |
Q2 2022 | $8,131,000 | -5.3% | 14,764 | -9.2% | 0.58% | +4.1% |
Q1 2022 | $8,586,000 | -13.3% | 16,264 | -13.3% | 0.56% | -27.8% |
Q4 2021 | $9,907,000 | – | 18,764 | – | 0.77% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 18,764 | $9,907,000 | 0.77% |
Pentwater Capital Management LP | 46,411,000 | $24,770,000 | 0.27% |
WHITEBOX ADVISORS LLC | 22,500,000 | $11,756,000 | 0.24% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 20,000,000 | $10,993,000 | 0.23% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 17,590,000 | $9,286,000 | 0.20% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 24,000,000 | $12,540,000 | 0.18% |
BlueCrest Capital Management Ltd | 7,000,000 | $3,705,000 | 0.12% |
DCF Advisers, LLC | 400,000 | $211,000 | 0.09% |
Walleye Capital LLC | 5,000 | $2,638,000 | 0.08% |
INGALLS & SNYDER LLC | 883,000 | $461,000 | 0.02% |